rxstat › Classes › Cardiac Stimulants Excl. Cardiac Glycosides

Cardiac Stimulants Excl. Cardiac Glycosides: shortage status in Canada

4 of the 5 cardiac stimulants excl. cardiac glycosides rxstat tracks are currently in shortage in Canada. When one drug in a class is short, demand often shifts to its alternatives, so related drugs can tighten too; each page below shows which manufacturers are affected and the latest recovery estimates.

Epinephrine (Emerade) Partial shortage 1 of 12 reported products affected · est. return Aug 30, 2026 Isoproterenol Partial shortage 1 of 2 reported products affected · est. return Sep 18, 2026 Norepinephrine (Levophed) Partial shortage 1 of 5 reported products affected Phenylephrine (Neo-Synephrine) Partial shortage 3 of 8 reported products affected · est. return Aug 24, 2026 Midodrine No current shortage

Guides: what to do when your medication is in shortage · how to read these statuses

Class groupings follow the WHO ATC classification in Health Canada's reports. Data reflects manufacturer mandatory filings; see methodology.